Systemic sclerosis. A vascular perspective

Rheumatic Disease Clinics of North America

Volumn 22, Issue 4, 1996, Pages 675-694

  LeRoy, E C ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CELL ADHESION MOLECULE; CYTOKINE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; DISEASE ACTIVITY; ENDOTHELIUM; HUMAN; IMMUNITY; MAST CELL; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; VASCULAR DISEASE; VASOSPASM;

EID: 0029905937     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70295-7     Document Type: Article

References (54)

1. A.L. Angiolillo C. Sgadari D.D. Taub Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo J Exp Med 182 1995 155 162
2. Arenberg D, Polverini P, Kunkel S, et al. C-X-C chemokines display disparate angiogenic activity [abstract]. In Federation Proceedings of the Federation of American Societies for Experimental Biology Meeting, V104 Abstracts, 1995, A587.
3. F.C. Arnett HLA and autoimmunity in scleroderma (systemic sclerosis) Int Rev Immunol 12 1995 107 128
4. F.C. Arnett J.D. Reveille R. Goldstein Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): An immunogenetic serologic and clinical analysis Arthritis Rheum 1996 in press
5. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels Cell 79 1994 1157 1164
6. Y. Cao C. Chen J.A. Weatherbee Gro-β, a-c-x-c chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice J Exp Med 182 1995 2069 2077
7. J.D. Coffman Raynaud's phenomenon J Vasc Med Biol 5 1994 259 269
8. K.M. Dameron O.V. Volpert M.A. Tainsky Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 Science 265 1994 1582 1584
9. P. Dessein B. Joffe R.V. Metz Autonomic dysfunction in systemic sclerosis: Sympathetic overactivity and instability Am J Med 93 1992 143 150
10. H.F. Dvorak M. Detmar K.P. Claffey Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation Int Arch Allergy Immunol 107 1995 233 235
11. E. Dwyer R. Winchester The role of the trimolecular complex (αβTCR-MHC+peptide) in the pathogenesis of systemic sclerosis. In Korn J, LeRoy C (eds): The Immunopathogenesis of Systemic Sclerosis Int Rev Immunol 12 1995 85 96
12. D. Fivenson D. Faria B. Nickoloff C-x-c chemokine efflux during chronic wound healing: critical role of the elr motif in angiogenesis [abstract] Federation Proceedings 104 1995 625
13. B.L. Gruber Mast cells: Accessory cells which potentiate fibrosis Int Rev Immunol 12 1995 259 279
14. M.S. Gruschwitz O.P. Hornstein P. Driesch Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity Arthritis Rheum 38 1995 184 189
15. N. Inoue R.C. Venema H.S. Sayegh Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-β Arterioscler Thromb Vasc Biol 15 1995 1255 1261
16. S. Jimenez A. Diaz K. Khalili Retroviruses and the pathogenesis of systemic sclerosis Int Rev Immunol 12 1995 159 175
17. M.B. Kahaleh The vascular endothelium in scleroderma Int Rev Immunol 12 1995 227 245
18. M.B. Kahaleh G.K. Sherer E.C. LeRoy Endothelial injury in scleroderma J Exp Med 149 1979 1326 1335
19. G. Karsenty R. Park Regulation of type-I collagen genes expression Int Rev Immunol 12 1995 177 185
20. L.M. Khachigian N. Resnick M.A. Gimborne Jr Nuclear factor-kb interacts functionally with the platelet-derived growth factor b-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress J Clin Invest 96 1995 1169 1175
21. H. Kiener W. Graninger K. Machold Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis Clin Exp Rheumatol 12 1994 483 487
22. J.H. Korn E.C. LeRoy The immunopathogenesis of systemic sclerosis Int Rev Immunol 12 1995 1 291
23. T.S. Kupper Adhesion molecules in scleroderma: Collagen binding integrins Int Rev Immunol 12 1995 217 225
24. B. Lee J. Craft Molecular structure and function of autoantigens in systemic sclerosis Int Rev Immunol 12 1995 129 144
25. E.C. LeRoy T.A. Medsger Raynaud's phenomenon: A proposal for classification Clin Exp Rheumatol 10 1992 485 488
26. M.A. Lofti J. Varga I.H. Hirsch Erectile dysfunction in systemic sclerosis Urology 45 1995 879 881
27. M. Luggen L. Belhorn T. Evans The evolution of Raynaud's phenomenon: A long-term prospective study J Rheumatol 22 1995 2226 2232
28. A.D. Luster S. Greenberg P. Leder The Ip-10 chemokine binds to a specific cell surface heparan sulfate shared with platelet factor 4 and inhibits endothelial cell proliferation J Exp Med 182 1995 219 231
29. H.R. Maricq M.C. Weinrich Diagnosis of Raynaud's phenomenon assisted by color charts J Rheumatol 15 1988 454 459
30. T.A. McCaffrey S. Consigli B. Du Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions J Clin Invest 96 1995 2667 2675
31. C.J. Meiniger C.J. Kelly A role for Steel factor in angiogenesis FASEB J 104 1995 260a
32. K. Miyazono K. Ichijo C.H. Heldin Transforming growth factor-β: Latent forms, binding proteins, and receptors Growth Factors 8 1993 11 22
33. R. Morishita G.H. Gibbons K.E. Ellison Evidence for direct local effect of angiotensin in vascular hypertrophy J Clin Invest 94 1994 978 984
34. T. Mustonen K. Alitalo Endothelial receptor tyrosine kinases involved in angiogenesis J Cell Biol 129 1995 895 898
35. A. Passaniti R.M. Taylor R. Pili Methods in laboratory investigation: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor Lab Invest 67 1992 519 528
36. L. Pertovaara A. Kaipainen T. Mustonen Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells J Biol Chem 269 1994 6271 6274
37. J. Peter Y. Shoenfeld Autoantibodies. 1996 Elsevier Science Amsterdam 1 890
38. A. Postlethwaile Role of T cells and cytokines in effecting fibrosis Int Rev Immunol 12 1995 247 258
39. P. Rameshwar T.N. Denny D. Stein Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines J Immunol 94 1994 2819 2829
40. S.M.F. Ribeiro S. Schultz-Cherry J.E. Murphy-Ullrich Heparin-binding vitronectin up-regulates latent TGF-β production by bovine aortic endothelial cells J Cell Sci 108 1995 1553 1561
41. W.G. Roberts G.E. Palade Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor J Cell Sci 108 1995 2369 2379
42. L.I. Romero D.N. Zhang G.S. Herron Isolation and immunoaffinity purification of microvascular endothelial cells from skin biopsies of scleroderma patients [abstract] J Invest Dermatol 105 1995 608
43. R. Silver Interstitial lung disease of systemic sclerosis Int Rev Immunol 12 1995 281 291
44. T. Sugihara S.C. Kaul Y. Mitsui Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblasts Biochim Biophys Acta 1224 1994 365 370
45. αQ antigen receptor in patients with systemic sclerosis J Exp Med 182 1995 1163 1168
46. L. Summers E.C. LeRoy Raynaud's phenomenon in clinical dermatology D.J. Demis Clinical Dermatology. 1995 Lippincott-Raven Philadelphia 1 8
47. C. Sunberg M. Ivarsson G. Gerdin Pericytes as collagen-producing cells in excessive dermal scarring Lab Invest 74 1996 1 15
48. S. Toms E. Cooke A comparison of the functioning of arteriovenous anastomoses in secondary Raynaud's phenomenon and control subjects in response to local hand warming Int Angiol 14 1995 74 79
49. J. Varga R.I. Bashey Regulation of connective tissue synthesis in systemic sclerosis Int Rev Immunol 12 1995 187 199
50. M. Vayasairat N. Baudot J.P. Gaitz Raynaud's phenomenon together with antinuclear antibodies: A common subset of incomplete connective tissue disease J Am Acad Dermatol 32 1995 747 749
51. D. Va´zquez-Abad N. Rothfield Autoantibodies in systemic sclerosis Int Rev Immunol 12 1995 145 157
52. J.V. de Water S.A. Jimenez M.E. Gershwin Animal models of scleroderma: Contrasts and comparisons Int Rev Immunol 12 1995 201 216
53. F.M. Wigley R.A. Wise J.R. Seibold Intravenous iloprost infusion in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter placebo-controlled double-blind study Ann Intern Med 120 1994 199 206
54. V. Yurovsky B. White T-cell repertoire in systemic sclerosis Int Rev Immunol 12 1995 97 105